Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Vivek Reddy Added: 1 month ago
HRS 25 - First-in-human data from the FIH VCAS trial suggests the FieldForce Ablation system can effectively create transmural ablation lesions in patients with scar-related ventricular tachycardia (VT), with an 80% freedom from VT and ventricular fibrillation rate at 6 months.We are joined by Dr Vivek Reddy (Mount Sinai Hospital, New York, US) to discuss the findings from the prospective, first… View more
Author(s): Pier D Lambiase Added: 2 months ago
EHRA 2025 - We are joined onsite at EHRA Congress 2025 by Prof Pier Lambiase to discuss the latest developments in ventricular tachycardia substrate identification from the EHRA Ablation Summit 2025.Interview Questions:What are the key challenges or limitations that still exist in accurately identifying VT substrates?What are the most significant recent advancements in techniques or technologies… View more
Author(s): Roderick Tung Added: 2 years ago
Following the success of Rhythm Interventions Online 2022 (30 November – 2 December 2022), here Course Co-director and operator Dr Roderick Tung reviews his HD Grid Mapping in Complex VT case performed live at the event. Includes comment and insight from fellow course leaders Prof Richard Schilling(St Bartholomew's Hospital, London, UK), Prof Julian Chun(CCB Markus Krankenhaus, Frankfurt, DE)… View more
Author(s): Frédéric Sacher Added: 2 months ago
EHRA 2025 - Positive safety results of the Affera mapping and ablation system for the treatment of ventricular arrhythmias (VA) show a 6% rate of major complication.Dr Frédéric Sacher (IHU Liryc, Bordeaux, FR) joins us on-site at EHRA Congress 2025 to discuss safety results from the European Affera Ventricular Arrhythmia Ablation Registry, investigating VA ablation with the Affera Sphere-9… View more